Company News

Ceapro Details PGX Technology at SCC Annual Meeting

Biotech company focused on the development and commercialization of active ingredients.

Author Image

By: Christine Esposito

Editor-in-Chief

Paul Moquin, Ph.D., director of scientific affairs and new business development at Ceapro, Inc., a biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries,  presented  a poster on “PGX Technology: a disruptive green platform technology to generate tuneable nanoporous water-soluble biopolymer delivery systems for bioactives,” at the Society of Cosmetic Chemists’ 72ndAnnual Scientific Meeting & Technology Showcase.  ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters